13F filer · CIK 1510481 ↗
Sarasin & Partners LLP
You are looking at Q1 2023. See the latest, Q3 2026 →
Reported value
$18.57B
+143% on the quarter before
Positions
101
13 new · 2 sold out
Top 10
37.5%
of the value
Est. gain
+$1.56B
on stocks held all quarter
Est. return
+21.0%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Sarasin & Partners LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$551.2MAdded · 5.5% → 5.8%+1,825,483 shares
- Cme Group Inc~$509.1MAdded · 4.8% → 5.2%+2,464,368 shares
- Colgate Palmolive Co~$391.2MAdded · 2.6% → 3.2%+4,859,184 shares
- Merck & Co Inc~$378.5MAdded · 4.6% → 3.6%+4,126,064 shares
- Home Depot Inc~$354.1MAdded · 0.1% → 2.0%+917,894 shares
- Amgen Inc~$353.9MAdded · 3.3% → 3.1%+1,514,172 shares
- Alphabet~$331.6MAdded · 0.8% → 2.3%+2,483,054 shares
- Mastercard~$325.2MAdded · 4.4% → 3.7%+886,179 shares
- Deere & Co~$318.2MAdded · 3.8% → 3.2%+811,478 shares
- Jpmorgan Chase & Co~$315.7MAdded · 0.1% → 1.7%+2,052,777 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Medical Pptys Trust Inc~$107.7MCut · 0.9% → 0.2%−4,630,203 shares
- Svb Financial Group~$59.9MSold out · 0.8% → 0.0%−260,449 shares
- First Rep Bk San Francisco C~$52.9MCut · 1.4% → 0.7%−259,104 shares
- Thermo Fisher Scientific Inc~$37.2MCut · 2.2% → 0.8%−64,547 shares
- Booking Holdings Inc~$10.9MCut · 0.5% → 0.2%−4,128 shares
- Alphabet~$5.4MCut · 2.6% → 1.9%−3,480 shares
- Mosaic Co New~$3.2MCut · 0.1% → 0.0%−70,000 shares
- Abcam Plc~$1.1MSold out · 0.0% → 0.0%−72,711 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +103% · price +25.9% | 5.8% | $1.08B | +$109.7M | ||||||||
| Cme Group IncCOM · shares +113% · price +22.8% | 5.2% | $960.0M | +$83.9M | ||||||||
| AmazonCOM · shares +18% · price +180.4% | 3.7% | $688.5M | +$374.1M | ||||||||
| MastercardCL A · shares +91% · price +5.5% | 3.7% | $681.2M | +$18.7M | ||||||||
| Merck & Co IncCOM · shares +131% · price −17.3% | 3.6% | $667.4M | −$60.5M | ||||||||
| Colgate Palmolive CoCOM · shares +190% · price +2.2% | 3.2% | $597.3M | +$4.4M | ||||||||
| Deere & CoCOM · shares +119% · price −8.5% | 3.2% | $585.9M | −$25.0M | ||||||||
| Walt Disney Company (The)COM · shares +59% · price +41.1% | 3.1% | $584.8M | +$107.3M | ||||||||
| Amgen IncCOM · shares +156% · price −11.0% | 3.1% | $580.2M | −$28.0M | ||||||||
| Otis Worldwide CorpCOM · shares +110% · price +7.7% | 2.9% | $533.6M | +$18.3M | ||||||||
| AramarkCOM · shares +135% · price −12.6% | 2.7% | $508.0M | −$31.1M | ||||||||
| TSMCSPONSORED ADS · shares +72% · price +42.8% | 2.7% | $492.4M | +$85.7M | ||||||||
| Middleby CorpCOM · shares +156% · price +34.3% | 2.6% | $476.1M | +$47.6M | ||||||||
| EquinixCOM · shares +137% · price +15.0% | 2.4% | $443.9M | +$24.4M | ||||||||
| AlphabetCAP STK CL A · shares +349% · price +51.3% | 2.3% | $426.5M | +$32.2M | ||||||||
| Costco Whsl Corp NewCOM · shares +194% · price +14.6% | 2.2% | $416.5M | +$18.1M | ||||||||
| Hdfc Bank LtdSPONSORED ADS · shares +109% · price +0.9% | 2.2% | $401.6M | +$1.8M | ||||||||
| BroadcomCOM · shares +89% · price +12.8% | 2.0% | $369.3M | +$22.2M | ||||||||
| Home Depot IncCOM · shares +2,699% · price +22.1% | 2.0% | $367.2M | +$2.4M | ||||||||
| Illumina IncCOM · shares +110% · price +51.1% | 1.9% | $356.5M | +$57.5M | ||||||||
| AlphabetCAP STK CL C · shares −1.5% · price +74.9% | 1.9% | $347.2M | +$148.6M | ||||||||
| Service Corp IntlCOM · shares +105% · price −2.9% | 1.8% | $334.8M | −$4.8M | ||||||||
| Jpmorgan Chase & CoCOM · shares +3,471% · price +14.7% | 1.7% | $324.8M | +$1.2M | ||||||||
| Nextera Energy IncCOM · shares +24,039% · price +3.3% | 1.7% | $316.3M | +$42,041 | ||||||||
| Moody's CorporationCOM · shares +141% · price +24.2% | 1.7% | $311.7M | +$25.2M | ||||||||
| Total · 101 positions | 100% | $18.57B | +$1.56B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 88 stocks held throughout, up $1.56B (+21.0%).
- Amazon+$374.1M+180%
- Alphabet1:10 split+$148.6M+75%
- Microsoft+$109.7M+26%
- Walt Disney Company (The)+$107.3M+41%
- TSMC+$85.7M+43%
- Deere & Co−$25.0M−9%
- Amgen Inc−$28.0M−11%
- Aramark−$31.1M−13%
- International Flavors&Fragra−$33.0M−10%
- Merck & Co Inc−$60.5M−17%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 13, 2026 | $8.93B+5% | SEC ↗ |
| Q2 2026 | Jul 7, 2026 | $8.54B+4% | SEC ↗ |
| Q1 2026 | Apr 13, 2026 | $8.20B−15% | SEC ↗ |
| Q4 2025 | Jan 8, 2026 | $9.63B−5% | SEC ↗ |
| Q3 2025 | Oct 10, 2025 | $10.19B+1% | SEC ↗ |
| Q2 2025 | Jul 9, 2025 | $10.05B+9% | SEC ↗ |
| Q1 2025 | Apr 15, 2025 (amended) | $9.22B+2% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $9.06B−14% | SEC ↗ |
| Q3 2024 | Oct 9, 2024 | $10.60B−6% | SEC ↗ |
| Q2 2024 | Jul 19, 2024 | $11.29B+11% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $10.16B+12% | SEC ↗ |
| Q4 2023 | Jan 10, 2024 | $9.10B+14% | SEC ↗ |
| Q3 2023 | Oct 5, 2023 | $8.01B−7% | SEC ↗ |
| Q2 2023 | Jul 11, 2023 | $8.62B−54% | SEC ↗ |
| Q1 2023 | Apr 27, 2023 (amended) | $18.57B+143% | SEC ↗ |
| Q4 2022 | Jan 30, 2023 | $7.64B+6% | SEC ↗ |
| Q3 2022 | Oct 18, 2022 | $7.22B−9% | SEC ↗ |
| Q2 2022 | Jul 13, 2022 | $7.93B−20% | SEC ↗ |
| Q1 2022 | Apr 11, 2022 | $9.95B−9% | SEC ↗ |
| Q4 2021 | Jan 19, 2022 | $10.98B+11% | SEC ↗ |
| Q3 2021 | Oct 22, 2021 | $9.91B+3% | SEC ↗ |
| Q2 2021 | Jul 13, 2021 | $9.58B+13% | SEC ↗ |
| Q1 2021 | Apr 29, 2021 | $8.48B+12% | SEC ↗ |
| Q4 2020 | Jan 19, 2021 | $7.56B+9% | SEC ↗ |
| Q3 2020 | Nov 9, 2020 | $6.91B+11% | SEC ↗ |
| Q2 2020 | Jul 17, 2020 | $6.25B+23% | SEC ↗ |
| Q1 2020 | Apr 30, 2020 | $5.09B−22% | SEC ↗ |
| Q4 2019 | Feb 12, 2020 | $6.54B+8% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $6.04B+6% | SEC ↗ |
| Q2 2019 | Jul 18, 2019 | $5.72B+10% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $5.19B+13% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $4.60B−13% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $5.31B+4% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $5.09B−0% | SEC ↗ |
| Q1 2018 | May 1, 2018 | $5.11B−1% | SEC ↗ |
| Q4 2017 | Feb 6, 2018 | $5.15B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $4.96B−3% | SEC ↗ |
| Q2 2017 | Aug 3, 2017 | $5.11B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $5.14B−13% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $5.91B−7% | SEC ↗ |
| Q3 2016 | Oct 14, 2016 | $6.38B+6% | SEC ↗ |
| Q2 2016 | Jul 14, 2016 | $6.02B−2% | SEC ↗ |
| Q1 2016 | Apr 27, 2016 | $6.13B | SEC ↗ |